Evaluation of SYS6005 in Patients With Advanced Malignant Tumor

Clinical trial NCT06958679 · RECRUITING

Trial details

NCT number: NCT06958679
Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Malignancies Solid Tumors

Start date: 2025-04-03
Primary completion: 2027-01-30
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.